HomeGDTC • NASDAQ
add
CytoMed Therapeutics Ltd
Previous close
$2.10
Day range
$2.00 - $2.12
Year range
$1.92 - $9.25
Market cap
23.71M USD
Avg Volume
6.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(SGD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 111.76K | -22.76% |
Operating expense | 1.02M | 55.43% |
Net income | -987.39K | 7.54% |
Net profit margin | -883.53 | -19.70% |
Earnings per share | — | — |
EBITDA | -818.70K | -97.72% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
(SGD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.00M | 469.41% |
Total assets | 12.37M | 136.63% |
Total liabilities | 1.12M | -75.76% |
Total equity | 11.24M | — |
Shares outstanding | 11.54M | — |
Price to book | 2.14 | — |
Return on assets | -18.32% | — |
Return on capital | -19.39% | — |
Cash Flow
Net change in cash
(SGD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -987.39K | 7.54% |
Cash from operations | -699.56K | -53.14% |
Cash from investing | -1.41M | -5,388.64% |
Cash from financing | -257.00 | -100.05% |
Net change in cash | -2.11M | -4,652.40% |
Free cash flow | -501.49K | -88.71% |
About
Founded
2018
Website
Employees
28